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easles has caused millions of 
deaths since its emergence 
thousands of years ago, 
probably as a zoonosis [1]. Deaths from 
measles are due largely to an increased 
susceptibility to secondary bacterial 
and viral infections. This period of 
increased susceptibility lasts for several 
weeks to months after the onset of rash 
[2] and is attributed to a prolonged 
state of immune suppression. Most 
deaths associated with measles are due 
to pneumonia [3]. Although the global 
mortality from measles is falling [4], a 
new study in PLoS Medicine found that 
children in Nigeria, Niger, and Chad 
still recently faced unacceptably high 
mortality from measles [5], a largely 
preventable disease. 
Measles Case Fatality Ratios
Measles case fatality ratios vary 
depending upon the average age 
of infection, the nutritional status 
of the population, measles vaccine 
coverage, and access to health care. In 
developed countries, less than one in 
1,000 children with measles die. But in 
endemic areas in sub-Saharan Africa, 
the measles case fatality ratio often 
ranges from 5%–10%. 
Measles is a major cause of child 
death in refugee camps and in 
internally displaced populations, 
and case fatality ratios in children in 
complex emergencies have been as 
high as 20%–30%. For example, during 
a famine in Ethiopia, measles alone or 
in combination with wasting accounted 
for 22% of 159 deaths among children 
younger than ﬁ  ve years of age, and 17% 
of 72 deaths among children aged ﬁ  ve 
to 14 years [6]. 
The risk of death following measles 
is highest at extremes of age and in 
those with underlying malnutrition and 
vitamin A deﬁ  ciency. Exposure to an 
index case within the household may 
result in more severe disease, perhaps 
because of transmission of a larger 
inoculum of virus [7]. 
Interestingly, data suggest that 
measles mortality may be higher in 
girls. Among persons of different ages 
and across different regions (primarily 
in the Americas and Europe), measles 
mortality in girls was estimated to 
be 5% higher than in boys [8]. 
Supporting the hypothesis of biological 
differences in the response to measles 
virus between boys and girls was the 
observation that girls were more likely 
than boys to have delayed mortality 
following receipt of high-titer measles 
vaccine [9]. 
Measles Vaccination
Vaccinated children, should they 
develop disease after exposure, have 
less severe disease and signiﬁ  cantly 
lower mortality rates. Vaccination 
programs, by increasing the average 
age of infection, shift the burden of 
disease out of the age group with the 
highest case fatality (infancy), further 
reducing measles mortality. 
Several attenuated measles vaccines 
are available worldwide, either as 
single-virus vaccines or in combination 
with other vaccine viruses (commonly 
rubella and mumps). The proportion 
of children who develop protective 
antibody levels following measles 
vaccination depends on the presence of 
inhibitory maternal antibodies and the 
immunological maturity of the vaccine 
recipient, as well as the dose and strain 
of vaccine virus. About 85% of children 
develop protective antibody levels when 
the measles vaccine is administered 
at nine months of age, and 90%–95% 
have a protective antibody response 
after vaccination at 12 months of 
age [10]. Most children who do not 
respond to a ﬁ  rst dose of measles 
vaccine will respond to a second 
dose at an older age. The duration of 
protective antibody levels following 
measles vaccination is more variable 
and shorter than that acquired through 
infection with wild-type measles virus, 
with an estimated 5% of children losing 
protective antibody levels 10 to 15 years 
after vaccination [11]. 
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The Global Decline in Measles 
Mortality 
Prior to the development and 
widespread use of measles vaccines, 
measles was estimated to result in 
5 to 8 million deaths annually. The 
decline in mortality from measles in 
developed countries was associated 
with economic development, improved 
nutritional status and supportive care, 
and antibiotic therapy for secondary 
bacterial pneumonia, as well as the 
widespread use of measles vaccine. 
In 2003, the World Health Assembly 
endorsed a resolution urging member 
countries to reduce the number of 
deaths attributed to measles by 50% 
by the end of 2005 compared with 
1999 estimates, a target that is likely to 
have been met. Overall global measles 
mortality in 2004 was estimated to be 
454,000 deaths (uncertainty bounds 
329,000 and 596,000 deaths), a 48% 
decrease from 1999 [4]. Following this 
success, the global measles control goal 
now is to reduce the annual number 
of measles deaths by 90% by 2010 
compared to the estimated number in 
2000.
Remarkable progress in reducing 
measles incidence and mortality has 
been made in parts of sub-Saharan 
Africa as a consequence of increasing 
measles vaccine coverage, provision 
of a second opportunity for measles 
vaccination through supplementary 
immunization activities, improved 
case management, and enhanced 
surveillance with laboratory 
conﬁ  rmation of measles cases [12]. 
This accelerated measles control 
strategy began in 2001 with the support 
of the Global Alliance for Vaccines 
and Immunization (http:⁄⁄www.
gavialliance.org) and the Measles 
Initiative (http:⁄⁄www.measlesinitiative.
org). 
Recent Outbreaks in Three African 
Countries: A New Study
How successful has this accelerated 
measles control strategy been? One 
measure of success is the recent 
demonstration of measles outbreaks in 
countries where these strategies had not 
been implemented. 
The new study in PLoS Medicine, 
by Rebecca Grais and colleagues, 
provides estimates of measles attack 
rates and age-speciﬁ  c case fatality 
ratios during large measles outbreaks 
in Niger, Chad, and Nigeria during 
2004–2005 [5]. The authors conducted 
retrospective household surveys in 
one neighborhood of each affected 
area at a time when the measles 
outbreak was subsiding, encompassing 
a total population surveyed of over 
64,000 individuals. Routine measles 
vaccine coverage rates were low, 
supplementary immunization activities 
had not yet been conducted, access to 
health care was poor, and responses 
to the outbreaks were delayed, an 
epidemiological situation conducive to 
the rapid spread of measles virus with 
high rates of morbidity and mortality. 
Almost 3,200 cases of measles were 
identiﬁ  ed in the study areas with 
age-speciﬁ  c attack rates of 17% to 
24% in children less than ﬁ  ve years 
of age. About two-thirds of persons 
with measles developed respiratory 
complications and diarrhea. The case 
fatality ratio ranged from 2.8% to 7% 
and was highest in children less than 
ﬁ  ve years of age. Most deaths occurred 
in unvaccinated children and at home. 
In rural Nigeria the risk of death was 
higher in girls than boys.
Although subject to potential 
recall and misclassiﬁ  cation biases, the 
estimates of morbidity and mortality 
during these large outbreaks of measles 
in Niger, Chad, and Nigeria are 
consistent with prior estimates obtained 
in similar epidemiological settings. The 
population surveyed was large and the 
non-participation rate was small. 
Implications of the Study
At a time of accelerated measles 
control in sub-Saharan Africa, these 
estimates serve as a reminder of the 
devastating impact measles can have 
in unvaccinated populations. During 
the outbreak, half of all deaths in 
children less than ﬁ  ve years of age 
were attributed to measles. Prompt 
recognition and response to measles 
outbreaks, in addition to appropriate 
case management, is critical to 
reducing measles morbidity and 
mortality and preventing further 
transmission of measles virus. 
These outbreaks also should serve as 
a reminder to communities in resource-
rich countries of the importance 
of measles vaccination and the 
potential for imported measles cases 
to spark outbreaks in unvaccinated 
communities. Following the reported 
outbreaks in Niger, Chad, and 
Nigeria, accelerated measles control 
strategies were implemented in the 
affected areas, including mass measles 
vaccination campaigns. However, 
only sustained efforts to maintain 
high coverage rates of the routine 
ﬁ  rst dose of measles vaccine, coupled 
with periodic opportunities for a 
second dose, will achieve the level of 
population immunity required to avert 
the unacceptably high morbidity and 
mortality rates that result from measles 
epidemics in susceptible populations.  
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